TREM2 drives monocyte-derived macrophage responses to Cryptococcus neoformans

Insights

The TREM2-DAP12 pathway inhibits the immune response to Cryptococcus neoformans by suppressing macrophage activation and fungal uptake. This pathway is initiated by TREM2 directly sensing the fungus.

Area of Science:

  • Immunology
  • Mycology
  • Infectious Diseases

Background:

  • Cryptococcus neoformans causes serious infections.
  • DAP12 signaling worsens host survival during cryptococcosis.
  • Mechanisms initiating DAP12 signaling in cryptococcosis are unclear.

Purpose of the Study:

  • Identify the DAP12-associated receptor initiating signaling during C. neoformans infection.
  • Elucidate the role of this receptor in macrophage response and host immunity.

Main Methods:

  • Investigated TREM2 expression on murine monocytes and macrophages during C. neoformans infection.
  • Assessed the impact of TREM2 on fungal uptake and macrophage polarization.
  • Utilized in vitro binding assays to study TREM2-fungal interactions.

Main Results:

  • TREM2 is induced on lung macrophages in response to C. neoformans.
  • TREM2 signaling inhibits fungal uptake and M1 polarization by macrophages.
  • TREM2 directly binds C. neoformans, dependent on the β-1,6-glucan antigen.

Conclusions:

  • The TREM2-DAP12 pathway inhibits host immune response to C. neoformans.
  • TREM2 acts as a direct sensor for C. neoformans, impeding macrophage activation and phagocytosis.